Gabapentin-equation (Gabapentin Equation)
Gabapentin
Product Images NDC 50090-5125
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Gabapentin Fig1
This appears to be results of a study on pain management. Participants underwent a 4-week dose titration period, followed by a 4-week fixed dose period. The mean pain score was 10 at baseline. The study compared the effects of a placebo versus Gabapentin, with a dosage of 3600 mg/day. However, there is not enough context to determine what the pain score represents or what specific types of pain were being evaluated.*
Gabapentin Fig2
Gabapentin Fig3
Gabapentin-fig4 (Gabapentin Fig4)
Gabapentin-struc (Gabapentin Struc)
Label Image (Lbl500905125)
This appears to be a product number and some associated information about "Remeentin" in the form of its strength (160 MG), recommended storage temperature and quantity (33 loose capsules). The text does not provide any further information about what "Remeentin" actually is or what it is used for, making it difficult to provide a more specific description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
